116 related articles for article (PubMed ID: 31730223)
1. Retraction Note to: Effect of whole-body vibration exercise on lumbar bone mineral density, bone turnover, and chronic back pain in post-menopausal osteoporotic women treated with alendronate.
Iwamoto J; Takeda T; Sato Y; Uzawa M
Aging Clin Exp Res; 2019 Dec; 31(12):1855. PubMed ID: 31730223
[TBL] [Abstract][Full Text] [Related]
2. Effect of whole-body vibration exercise on lumbar bone mineral density, bone turnover, and chronic back pain in post-menopausal osteoporotic women treated with alendronate.
Iwamoto J; Takeda T; Sato Y; Uzawa M
Aging Clin Exp Res; 2005 Apr; 17(2):157-63. PubMed ID: 15977465
[TBL] [Abstract][Full Text] [Related]
3. Articles retraction.
J Musculoskelet Neuronal Interact; 2018 Jun; 18(2):280. PubMed ID: 29855452
[TBL] [Abstract][Full Text] [Related]
4. Randomized trial comparing efficacies of zoledronate and alendronate for improving bone mineral density and inhibiting bone remodelling in women with post-menopausal osteoporosis.
Tan W; Sun J; Zhou L; Li Y; Wu X
J Clin Pharm Ther; 2016 Oct; 41(5):519-23. PubMed ID: 27440710
[TBL] [Abstract][Full Text] [Related]
5. Whole body vibration exercise improves body balance and walking velocity in postmenopausal osteoporotic women treated with alendronate: Galileo and Alendronate Intervention Trail (GAIT).
Iwamoto J; Sato Y; Takeda T; Matsumoto H
J Musculoskelet Neuronal Interact; 2012 Sep; 12(3):136-43. PubMed ID: 22947545
[TBL] [Abstract][Full Text] [Related]
6. Positive effect of alendronate on bone mineral density and markers of bone turnover in patients with rheumatoid arthritis on chronic treatment with low-dose prednisone: a randomized, double-blind, placebo-controlled trial.
Lems WF; Lodder MC; Lips P; Bijlsma JW; Geusens P; Schrameijer N; van de Ven CM; Dijkmans BA
Osteoporos Int; 2006; 17(5):716-23. PubMed ID: 16463007
[TBL] [Abstract][Full Text] [Related]
7. Retraction Note: Effects of alendronate on metacarpal and lumbar bone mineral density, bone resorption, and chronic back pain in postmenopausal women with osteoporosis.
Iwamoto J; Takeda T; Sato Y; Uzawa M
Clin Rheumatol; 2021 Aug; 40(8):3383. PubMed ID: 34143320
[No Abstract] [Full Text] [Related]
8. Determinants of one-year response of lumbar bone mineral density to alendronate treatment in elderly Japanese women with osteoporosis.
Iwamoto J; Takeda T; Sato Y; Uzawa M
Yonsei Med J; 2004 Aug; 45(4):676-82. PubMed ID: 15344210
[TBL] [Abstract][Full Text] [Related]
9. Enhancement of bone mass in osteoporotic women with parathyroid hormone followed by alendronate.
Rittmaster RS; Bolognese M; Ettinger MP; Hanley DA; Hodsman AB; Kendler DL; Rosen CJ
J Clin Endocrinol Metab; 2000 Jun; 85(6):2129-34. PubMed ID: 10852440
[TBL] [Abstract][Full Text] [Related]
10. Comparison of effect of treatment with etidronate and alendronate on lumbar bone mineral density in elderly women with osteoporosis.
Iwamoto J; Takeda T; Sato Y; Uzawa M
Yonsei Med J; 2005 Dec; 46(6):750-8. PubMed ID: 16385649
[TBL] [Abstract][Full Text] [Related]
11. Comparison of bone and total alkaline phosphatase and bone mineral density in postmenopausal osteoporotic women treated with alendronate.
Watts NB; Jenkins DK; Visor JM; Casal DC; Geusens P
Osteoporos Int; 2001; 12(4):279-88. PubMed ID: 11420777
[TBL] [Abstract][Full Text] [Related]
12. Effects of vibration therapy on bone mineral density in postmenopausal women with osteoporosis.
Ruan XY; Jin FY; Liu YL; Peng ZL; Sun YG
Chin Med J (Engl); 2008 Jul; 121(13):1155-8. PubMed ID: 18710630
[TBL] [Abstract][Full Text] [Related]
13. Bone mineral density and perceived menopausal symptoms: factors influencing low back pain in postmenopausal women.
Ahn S; Song R
J Adv Nurs; 2009 Jun; 65(6):1228-36. PubMed ID: 19374677
[TBL] [Abstract][Full Text] [Related]
14. The effect of continuous oestradiol with intermittent norgestimate on bone mineral density and bone turnover in post-menopausal women.
Arrenbrecht S; Caubel P; Garnero P; Felsenberg D
Maturitas; 2004 Jul; 48(3):197-207. PubMed ID: 15207885
[TBL] [Abstract][Full Text] [Related]
15. Differences of therapeutic effects on regional bone mineral density and markers of bone mineral metabolism between alendronate and alfacalcidol in Japanese osteoporotic women.
Takata S; Abbaspour A; Yonezu H; Yasui N
J Med Invest; 2007 Feb; 54(1-2):35-40. PubMed ID: 17380012
[TBL] [Abstract][Full Text] [Related]
16. Bone turnover and the response to alendronate treatment in postmenopausal osteoporosis.
Gonnelli S; Cepollaro C; Pondrelli C; Martini S; Montagnani A; Monaco R; Gennari C
Calcif Tissue Int; 1999 Nov; 65(5):359-64. PubMed ID: 10541760
[TBL] [Abstract][Full Text] [Related]
17. Effects of alendronate and calcitonin on bone mineral density in postmenopausal osteoporotic women. An observational study.
Hejdova M; Palicka V; Kucera Z; Vlcek J
Pharm World Sci; 2005 Jun; 27(3):149-53. PubMed ID: 16096879
[TBL] [Abstract][Full Text] [Related]
18. Effects of whole body vibration on bone mineral density in postmenopausal women: a systematic review and meta-analysis.
Oliveira LC; Oliveira RG; Pires-Oliveira DA
Osteoporos Int; 2016 Oct; 27(10):2913-33. PubMed ID: 27145947
[TBL] [Abstract][Full Text] [Related]
19. Effects of alendronate on bone metabolism in glucocorticoid-induced osteoporosis measured by 18F-fluoride PET: a prospective study.
Uchida K; Nakajima H; Miyazaki T; Yayama T; Kawahara H; Kobayashi S; Tsuchida T; Okazawa H; Fujibayashi Y; Baba H
J Nucl Med; 2009 Nov; 50(11):1808-14. PubMed ID: 19837766
[TBL] [Abstract][Full Text] [Related]
20. Serum adiponectin, bone mineral density and bone turnover markers in post-menopausal women with newly diagnosed Type 2 diabetes: a 12-month follow-up.
Miazgowski T; Noworyta-Ziętara M; Safranow K; Ziemak J; Widecka K
Diabet Med; 2012 Jan; 29(1):62-9. PubMed ID: 21726281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
